205 6 Cochrane review on integrated disease management for COPD Herbert 2018 Herbert RD, Kasza J, Bo K. Analysis of randomised trials with long-term follow-up. BMC Medical Research Methodology 2018;18(1):48. Higgins 2019b Higgins J T, Eldridge S, Li T. Chapter 16.5.4 . How to include multiple groups from one study c hapter ? In: Higgins JT, Thomas J, Chandler J, Cumpston M, Li J, Page MJ, Welch VA, editors(s). Cochrane Handbook for Systematic Reviews of Interventions. S eco nd edition. Chichester (UK): John Wi ley & Sons, 2019:569-93. Higgins 2011 Higgins JT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www. cochrane-handbook.org. Higgins 2019 Higgins JT, Savovic J, Page MJ, Elbers RG, Sterne JAC. Chapter 9.5.2. Identifying and measuring heterogeneity. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors(s). Cochrane Handbook for Systematic Reviews of Interventions. S eco nd edition. Chichester (UK): John Wiley & Sons, 2019:205-28. Higgins 2019a Higgins JT, Li T, Deeks JJ. Chapter 23.1.3 . Methods of analysis for cluster-randomized trials. In: Higgins JT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors(s). Cochrane Handbook for Systematic Reviews of Interventions. S eco nd edition. Chichester (UK): John Wiley & Sons, 2019:143-76. Hong 2019 Hong Y, Lee SH. E ectiveness of tele-monitoring by patient severity and intervention type in chronic obstructive pulmonary disease patients: a systematic review and meta-analysis. International Journal of Nursing Studies 2019;92:1-15. [PMID: 30690162 ] Howcroft 2016 Howcroft M, Walters EH, Wood-Baker R, Walters JAE. Action plans with brief patient education for exacerbations in chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2016, Issue 12. Art. No: CD005074. [DOI: 10.1002/14651858.CD005074.pub4 ] Hurst 2010 Hurst JR, Vestbo J, Anzueto A, Locantore N, Mullerova H, Tal-Singer R, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. New England Journal of Medicine 2010;363(12):1128-38. [PMID: 20843247 ] Janjua 2020 Janjua S, Fortescue R, Poole P. Phosphodiesterase-4 inhibitors for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2020, Issue 5. Art. No: CD002309. [DOI: 10.1002/14651858.CD002309.pub6 ] Jones 1991 Jones PW, Quirk FH, Baveystock CM. The St George’s Respiratory Questionnaire. Respiratory Medicine 1991;85 Suppl B:25-31; discussion 33-7. [PMID: 1759018 ]
RkJQdWJsaXNoZXIy MTk4NDMw